Carregant...
A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
In recent years, as our understanding of tumor immunology is continuously improved, immunotherapy has come to the center stage of cancer therapy and is deemed as the most promising approach for cancer control. Although immunotherapy, particularly immune checkpoint blockade (ICB), has achieved a mile...
Guardat en:
| Publicat a: | Front Cell Dev Biol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7746821/ https://ncbi.nlm.nih.gov/pubmed/33344447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.580140 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|